<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2021.732276</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Distinct Microbial Communities in Dilated Cardiomyopathy Explanted Hearts Are Associated With Different Myocardial Rejection Outcomes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pereira</surname>
<given-names>Jaqueline de Jesus</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1376542"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ikegami</surname>
<given-names>Renata Nishiyama</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/638732"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawakami</surname>
<given-names>Joyce Tiyeko</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/638710"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garavelo</surname>
<given-names>Sh&#xe9;rrira Menezes</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reis</surname>
<given-names>Marcia Martins</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1412755"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Palomino</surname>
<given-names>Suely Aparecida Pinheiro</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mangini</surname>
<given-names>Sandrigo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreno</surname>
<given-names>Camila Rodrigues</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1303524"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barros</surname>
<given-names>Samar Freschi de</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1289427"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Souza</surname>
<given-names>Aline Rodrigues</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Higuchi</surname>
<given-names>Maria de Lourdes</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/559382"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Instituto do Cora&#xe7;&#xe3;o (InCor), Hospital das Cl&#xed;nicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laborat&#xf3;rio de Patologia Card&#xed;aca, Departamento de Patologia, Instituto do Cora&#xe7;&#xe3;o (InCor), Universidade de S&#xe3;o Paulo</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ryan Oliver Marino Rego, Academy of Sciences of the Czech Republic (ASCR), Czechia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ajoy Kumar Verma, National Institute of Tuberculosis and Respiratory Diseases, India; Joseph Selvin, Pondicherry University, India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Maria de Lourdes Higuchi, <email xlink:href="mailto:anplourdes@incor.usp.br">anplourdes@incor.usp.br</email>; <uri xlink:href="https://orcid.org/0000-0002-1673-6456">orcid.org/0000-0002-1673-6456</uri>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>11</volume>
<elocation-id>732276</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>06</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Pereira, Ikegami, Kawakami, Garavelo, Reis, Palomino, Mangini, Moreno, Barros, Souza and Higuchi</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Pereira, Ikegami, Kawakami, Garavelo, Reis, Palomino, Mangini, Moreno, Barros, Souza and Higuchi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Idiopathic dilated cardiomyopathy (IDCM) myocardial inflammation may be associated with external triggering factors such as infectious agents. Here, we searched if moderate/severe heart transplantation rejection is related to the presence of myocardial inflammation in IDCM explanted hearts, associated with microbial communities.</p>
</sec>
<sec>
<title>Method</title>
<p>Receptor myocardial samples from 18 explanted hearts were separated into groups according to post-transplant outcome: persistent moderate rejection (PMR; n = 6), moderate rejection (MR; n = 7) that regressed after pulse therapy, and no rejection (NR; n = 5)/light intensity rejection. Inflammation was quantified through immunohistochemistry (IHC), and infectious agents were evaluated by IHC, molecular biology, <italic>in situ</italic> hybridization technique, and transmission electron microscopy (TEM).</p>
</sec>
<sec>
<title>Results</title>
<p>NR presented lower numbers of macrophages, as well as B cells (p = 0.0001), and higher HLA class II expression (p &#x2264; 0.0001). PMR and MR showed higher levels of <italic>Mycoplasma pneumoniae</italic> (p = 0.003) and hepatitis B core (p = 0.0009) antigens. NR presented higher levels of parvovirus B19 (PVB19) and human herpes virus 6 (HHV6) and a positive correlation between <italic>Borrelia burgdorferi</italic> (Bb) and enterovirus genes. Molecular biology demonstrated the presence of <italic>M. pneumoniae</italic>, Bb, HHV6, and PVB19 genes in all studied groups. TEM&#x202f;revealed structures compatible with the cited microorganisms.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>This initial study investigating on infectious agents and inflammation in the IDCM explanted hearts showed that the association between <italic>M. pneumoniae</italic> and hepatitis B core was associated with a worse outcome after HT, represented by MR and PMR, suggesting that different IDCM microbial communities may be contributing to post-transplant myocardial rejection.</p>
</sec>
</abstract>
<kwd-group>
<kwd>cardiomyopathy</kwd>
<kwd>infectious agents</kwd>
<kwd>transplantation</kwd>
<kwd>myocardial</kwd>
<kwd>rejection</kwd>
</kwd-group>
<contract-sponsor id="cn001">Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior<named-content content-type="fundref-id">10.13039/501100002322</named-content>
</contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="49"/>
<page-count count="9"/>
<word-count count="3733"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Idiopathic dilated cardiomyopathy (IDCM), a major cause of heart failure (HF) and heart transplantation (HT), has a still non-clarified etiology, with many theories proposed: viral, autoimmune, genetic, or idiopathic origin (<xref ref-type="bibr" rid="B7">Caforio et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B24">Kawai and Matsumori, 2013</xref>). Microbial communities have been described in humans and are considered decisive to maintain a healthy situation or to determine diseases (<xref ref-type="bibr" rid="B8">Cho and Blaser, 2012</xref>); changes in the composition of microbial community were associated with the worsening of several diseases including HF (<xref ref-type="bibr" rid="B45">Tang et&#xa0;al., 2017</xref>).</p>
<p>Patients with HF showed a significantly decreased diversity of the intestinal microbiome as well as a downregulation of key intestinal bacterial groups, pointing to an altered intestinal microbiome as a potential player in the pathogenesis and progression of HF (<xref ref-type="bibr" rid="B30">Luedde et&#xa0;al, 2017</xref>). Proteomic and metabolomic analyses of the blood show a distinct immune response and an unexpected link with pathology-specific microbiota in DCM (<xref ref-type="bibr" rid="B42">Seitaro, 2019</xref>).</p>
<p>Enterovirus is the most common pathogen observed in DCM, in addition to the human erythrovirus, such as parvovirus B19 (PVB19) (<xref ref-type="bibr" rid="B43">Stewart et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B2">Bachelier et&#xa0;al., 2017</xref>). Human herpes virus 6 (HHV6) infection is often detected in transplanted and immunosuppressed patients (<xref ref-type="bibr" rid="B28">Ljungman and Singh, 2006</xref>), although infections caused by transplant recipients are attributed to asymptomatic reactivation of the virus (<xref ref-type="bibr" rid="B27">Lautenschlager and Razonable, 2012</xref>). In addition, bacteria such as <italic>Borrelia burgdorferi</italic> (Bb) (<xref ref-type="bibr" rid="B38">Palecek et&#xa0;al., 2010</xref>) and <italic>Mycoplasma pneumoniae</italic> (<xref ref-type="bibr" rid="B25">Koskiniemi, 1993</xref>; <xref ref-type="bibr" rid="B35">Nagashima et&#xa0;al., 2010</xref>) were found in myocarditis.</p>
<p>In the present work, we characterized and quantified most of the reported antigens/DNA cardiac infectious agents in the DCM explanted heart, focusing on detection of a microbial community related with worse myocardial inflammation, which also could be related with development of persistent myocardial rejection after HT (<xref ref-type="bibr" rid="B13">Felker et al., 2000</xref>).</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Study Design</title>
<p>Myocardial samples from 18 IDCM explanted hearts were retrospectively studied. Based on medical reports, the patients were grouped according to the degree of rejection (up to 60 days after HT) considering the first episode of no evidence and mild/moderate/severe rejection (meaning 1R, 2R, or 3R), according to the International Society for Heart and Lung Transplantation (ISHLT) revision nomenclature (<xref ref-type="bibr" rid="B44">Stewart et&#xa0;al., 2005</xref>), being:</p>
<list list-type="order">
<list-item>
<p>Persistent moderate rejection (PMR, n = 6)&#x2014;myocardial fragments from patients who had PMR</p>
</list-item>
<list-item>
<p>Moderate rejection (MR; solved after pulse therapy, n = 7) myocardial fragments from patients who had MR</p>
</list-item>
<list-item>
<p>No rejection (NR; or mild rejection, n = 5) myocardial fragments from patients who did not have MR</p>
</list-item>
</list>
<p>The fragments were obtained from paraffin blocks of the Laboratory of Pathological Anatomy of the Heart Institute of S&#xe3;o Paulo State (InCor-HCFMUSP) and processed for immunohistochemical reactions for detection of antigens, inflammatory cells, and HLA class II expression; <italic>in situ</italic> hybridization (ISH) and qRT-PCR for gene quantification; and transmission electron microscopy (TEM) to identify infectious agents.</p>
<p>This study was approved by the Clinical Hospital of the Medical School of the University of S&#xe3;o Paulo Ethics Committee for Analysis of Research Projects under number 3703/11/121.</p>
</sec>
<sec id="s2_2">
<title>Immunohistochemistry</title>
<p>The histological sections used to study the immunohistochemical reaction for Bb (Lot. GR292767-1), <italic>M. pneumoniae</italic> (Lot. P12080102), HHV6 (Lot. FF996), hepatitis C virus (HCV) (Lot. GR202313-2), hepatitis B core (Lot. 10108647) and surface, PVB19 (Lot. 12X11017), enterovirus (Lot. 20028020), CD3 (Lot. 20025164), CD20 (Lot. 20007102), CD45 (Lot. 00048408), CD68 (Lot. M0814), and HLA class II expression (Lot. 20022894) were processed according to the protocol of <xref ref-type="bibr" rid="B46">Tiveron et&#xa0;al. (2017)</xref>.</p>
</sec>
<sec id="s2_3">
<title>Molecular Biology</title>
<sec id="s2_3_1">
<title>DNA Extraction and PCR Standardization</title>
<p>DNA extraction from the samples began with tissue dewaxing in xylol baths, followed by dehydration and rehydration in ethanol. After the pellet was obtained, the protocol described by <xref ref-type="bibr" rid="B5">Bettstetter et&#xa0;al. (2003)</xref> was followed, with adaptations. The DNA was extracted and purified using PureLink<sup>&#xae;</sup> Viral RNA/DNA Mini Kit (Invitrogen), according to the manufacturer&#x2019;s specifications. The sample&#x2019;s concentrations were determined by spectrophotometer reading at wavelength 260/280 nm using NanoDrop apparatus (Thermo Scientific), and the values were expressed in ng/&#x3bc;l. The primers were optimized before being tested on the PCR platform by performing a temperature gradient between 45&#xb0;C and 68&#xb0;C. Tissue or culture samples were used as positive controls for the studied agents, and as negative control, ultrapure water was used in place of the samples.</p>
</sec>
</sec>
<sec id="s2_4">
<title>Cloning <italic>Borrelia</italic> Gene</title>
<p>Cloning of gene Bb was performed according to the protocol of <xref ref-type="bibr" rid="B16">Guilherme et&#xa0;al. (2009)</xref> to obtain the positive control to perform the standard curve for real-time PCR quantification.</p>
</sec>
<sec id="s2_5">
<title>Absolute Quantification DNA Copies of Infectious Agents by Real-Time PCR</title>
<p>RT-PCR were performed on 96-well plates using Power SYBR Green Master Mix reagent (Applied Biosystems, USA) as described by the manufacturer and Step One Plus Real-Time PCR Systems equipment (Applied Biosystems). To determine the detection limit of qRT-PCR, standard curves with serial dilutions of extracted DNA were used from samples known to be positive for the genes of interest. All amplifications were terminated with the melting dissociation curve to verify the specificity and amplification and to confirm the absence of primer dimer formation or any other non-specific product.</p>
<p>Absolute quantification was performed for genomic amplification analysis, and all samples were tested in duplicate. The following DNAs sequences were studied: Bb F (GGC AAC CCT AAG GTG AAG GC) and R (GGT GAG CCA GGC CAT CAC TA); HHV6 F (CAA TGC TTT TCT AGC CGC CTC TTC) and R (ACA TCT ATA ATT TTA GAC GAT CCC); <italic>M. pneumoniae</italic> F (ATT ACC ATC CTT GTT GTA AG) and R (GAA GCT TAT GGT ACA GGT TGG); and PVB19 F (TTT CAA AGT CAT GGA CAG TTA TCT GA) and R (TTG TGT AAG TCT TCA CTA GAT AAT ACT GCA TT).</p>
</sec>
<sec id="s2_6">
<title>
<italic>In Situ</italic> Hybridization</title>
<p>ISH technique was used to detect <italic>M. pneumoniae</italic> DNA using the biotinylated probe CGTAAGCTATCAGCTACATGGAGG (50 ng/&#xb5;l). As a positive control, a known positive histological tissue was used for <italic>M. pneumoniae</italic>.</p>
</sec>
<sec id="s2_7">
<title>Transmission Electron Microscopy</title>
<p>Inclusion was performed following the procedure described by <xref ref-type="bibr" rid="B12">Duarte et&#xa0;al. (1992)</xref>, with adaptations. After selection of the best blocks, 70-nm-thick slices were cut with ultra-microtome and placed in 200 mesh parlodion copper-coated grids (reagent and grids from EMS Electron Microscopy Sciences, Hatfield, PA, USA). Grids were contrasted with lead citrate for analysis in TEM (JEOL JEM-1010; JEOL Ltd).</p>
</sec>
<sec id="s2_8">
<title>Methods of Analysis</title>
<p>After immunohistochemistry (IHC) and ISH processing, slides were scanned using a ScanScope CS System apparatus (Aperio Technologies, Inc., CA, USA) with 40&#xd7; Olympus UPlanSApo lens. This device was coupled to a scanner that generated image files in.svs format. The scanned images were analyzed using Aperio ImageScope View Software program (Aperio Technologies, Inc., CA, USA). The samples were analyzed using this tool, for viral, bacterial, and HLA class II antigens. For inflammatory cell analysis, the number of positive cells/400&#xd7; (an average of 20 fields) was quantified to define the average number of immune-stained cells. Results were expressed as cells per mm<sup>2</sup> (cells/mm<sup>2</sup>), and this number was divided by the value of 0.159, which is the diameter of the microscopic field at &#xd7;400 magnification.</p>
</sec>
<sec id="s2_9">
<title>Statistical Analysis</title>
<p>The software GraphPad Prism 6 was used for statistical calculations. Data for each variable were initially compared with the normal curve by the Kolmogorov&#x2013;Smirnov distance test, being classified as parametric and non-parametric. Parametric data were represented by means and SD, and the groups were compared by ANOVA. Non-parametric data were represented by median and interquartile ranges. The groups were compared by the Kruskal&#x2013;Wallis test. Spearman&#x2019;s method was used in the correlation analysis.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Inflammatory Profile</title>
<p>IHC detected higher numbers of CD68+ cells in the PMR group than the two groups (p = 0.005). CD20+ B-cell positive (p = 0.0001) and HLA expression were higher in the NR group (p &#x2264; 0.0001) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Quantification and comparison of inflammation parameters between groups, demonstrating a hyperactivation of macrophages and infers a better modulation of the immune response in the NR group, by the increase in memory cells. HLA class II expression is also shown to be elevated in this group, validating the result because this molecule also is expressed in B lymphocytes. ** &#x2264; 0,01; *** &#x2264; 0,001; **** &#x2264; 0,0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-732276-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Infectious Agents by Immunohistochemistry</title>
<p>There was a predominance of <italic>M. pneumoniae</italic> (p = 0.003) and HBc (p = 0.0009) antigens in the PMR and MR groups, compared with the NR group. In the NR group, there were increased levels of HHV6 (p = 0.01) and PVB19 antigens (p = 0.001) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Data obtained from all infectious antigens analyzed were expressed in the <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Percentage area of infectious agents in myocardial biopsies by immunohistochemistry. The presence of M. pneumoniae is significant in the groups that show more rejection. This bacteria has ability to modulate the inflammation cells, such as macrophages. * &#x2264; 0,05; ** &#x2264; 0,01; *** &#x2264; 0,001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-732276-g002.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Data obtained from quantification of the microorganisms by immunohistochemistry technique.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">&#xa0;</th>
<th valign="top" align="center">PMR</th>
<th valign="top" align="center">MR</th>
<th valign="top" align="center">NR</th>
<th valign="top" align="center">P</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>Bb</bold>
</td>
<td valign="top" align="center">10.1</td>
<td valign="top" align="center">12.2</td>
<td valign="top" align="center">14</td>
<td valign="top" rowspan="2" align="center">0.8</td>
</tr>
<tr>
<td valign="top" align="center">(7 &#x2013; 15.3)</td>
<td valign="top" align="center">(5.6 &#x2013; 15.2)</td>
<td valign="top" align="center">(6.6 &#x2013; 23.4)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>HBc</bold>
</td>
<td valign="top" align="center">31.6</td>
<td valign="top" align="center">21.7</td>
<td valign="top" align="center">0.8</td>
<td valign="top" rowspan="2" align="center">0.0009</td>
</tr>
<tr>
<td valign="top" align="center">(20.8 &#x2013; 44.2)</td>
<td valign="top" align="center">(18.8 - 30)</td>
<td valign="top" align="center">(0.3 &#x2013; 0.8)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>HBs</bold>
</td>
<td valign="top" align="center">1.15</td>
<td valign="top" align="center">1.7</td>
<td valign="top" align="center">1.5</td>
<td valign="top" rowspan="2" align="center">0.9</td>
</tr>
<tr>
<td valign="top" align="center">(0.4 &#x2013; 5.7)</td>
<td valign="top" align="center">(0.8 - 2)</td>
<td valign="top" align="center">(0.7 &#x2013; 4.6)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>HCV</bold>
</td>
<td valign="top" align="center">14</td>
<td valign="top" align="center">13</td>
<td valign="top" align="center">32</td>
<td valign="top" rowspan="2" align="center">0.08</td>
</tr>
<tr>
<td valign="top" align="center">(11.8 &#x2013; 20.7)</td>
<td valign="top" align="center">(10.8 &#x2013; 20.8)</td>
<td valign="top" align="center">(17.2 &#x2013; 47.5)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>HHV6</bold>
</td>
<td valign="top" align="center">10.2</td>
<td valign="top" align="center">8.8</td>
<td valign="top" align="center">30</td>
<td valign="top" rowspan="2" align="center">0.01</td>
</tr>
<tr>
<td valign="top" align="center">(6.1 &#x2013; 12.5)</td>
<td valign="top" align="center">(4.3 &#x2013; 10.8)</td>
<td valign="top" align="center">(16.2 &#x2013; 50.2)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>Enterovirus</bold>
</td>
<td valign="top" align="center">32.6</td>
<td valign="top" align="center">25.03</td>
<td valign="top" align="center">33.2</td>
<td valign="top" rowspan="2" align="center">0.3</td>
</tr>
<tr>
<td valign="top" align="center">(24.2 &#x2013; 37.2)</td>
<td valign="top" align="center">(18.7 &#x2013; 31.4)</td>
<td valign="top" align="center">(18.9 &#x2013; 36.3)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>
<italic>M. pneumoniae</italic>
</bold>
</td>
<td valign="top" align="center">29.9</td>
<td valign="top" align="center">33.1</td>
<td valign="top" align="center">3.3</td>
<td valign="top" rowspan="2" align="center">0.003</td>
</tr>
<tr>
<td valign="top" align="center">(24.1 &#x2013; 31.8)</td>
<td valign="top" align="center">(13.6 - 35)</td>
<td valign="top" align="center">(1.6 &#x2013; 8.6)</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>PB19</bold>
</td>
<td valign="top" align="center">3.2</td>
<td valign="top" align="center">2.3</td>
<td valign="top" align="center">18.2</td>
<td valign="top" rowspan="2" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="center">(1.5 &#x2013; 5.8)</td>
<td valign="top" align="center">(0.8 &#x2013; 5.5)</td>
<td valign="top" align="center">(9.1 &#x2013; 30.1)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>PMR, persistent moderate rejection; MR, moderate rejection; NR, no rejection; Bb, Borrelia burgdorferi; HCV, hepatitis C virus; HHV6, human herpes virus 6; PVB19, parvovirus B19.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Infectious Agents by Real-Time PCR</title>
<p>The presence of genomes from <italic>M. pneumoniae</italic> and Bb bacteria, and from HHV6 and PVB19 viruses, was evident in all patients (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). There was a higher amount of HHV6 gene in the NR versus MR group (p = 0.05).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Absolute quantification of infectious agents in myocardial biopsies. * Comparison MR &#xd7; NR group: p &lt; 0.05: HHV6.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-732276-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>
<italic>Mycoplasma pneumoniae</italic> by <italic>In Situ</italic> Hybridization</title>
<p>There was no difference in the amount of DNA among the groups (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> shows genome identification in myocardial tissue.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Presence of the <italic>Mycoplasma pneumoniae</italic> genome in the groups.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left"/>
<th valign="top" align="center">PMR</th>
<th valign="top" align="center">MR</th>
<th valign="top" align="center">NR</th>
<th valign="top" align="center">p</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="2" align="left">ISH <italic>M. pneumoniae</italic>
</td>
<td valign="top" rowspan="2" align="center">0.75 (0.6&#x2013;2.3)</td>
<td valign="top" rowspan="2" align="center">1.35 (1.3&#x2013;2.1)</td>
<td valign="top" rowspan="2" align="center">3.3 (0.55&#x2013;4.1)</td>
<td valign="top" rowspan="2" align="center">0.44</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>PMR, persistent moderate rejection; MR, moderate rejection; NR, no rejection; ISH, in situ hybridization.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>PMR myocardium: <bold>(A)</bold> The image shows the genome identification (yellow and red dots) by Aperio analysis. <bold>(B)</bold> The image shows the genome identification without the analysis method by software (Aperio).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-732276-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Correlation Between Microorganisms</title>
<p>The amount of <italic>M. pneumoniae</italic> DNA had an almost significant negative correlation with PVB19, Bb, and HCV antigens in the PMR group. In the NR group, the Bb DNA correlated with enterovirus antigen (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Correlation of antigen expression and molecular biology.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left"> </th>
<th valign="top" colspan="2" align="center">PMR</th>
<th valign="top" colspan="2" align="center">NR</th>
</tr>
<tr>
<th valign="top" align="center">r</th>
<th valign="top" align="center">p</th>
<th valign="top" align="center">r</th>
<th valign="top" align="center">p</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>
<italic>Mycoplasma pneumoniae</italic> &#xd7; PVB19</bold>
</td>
<td valign="top" align="center">&#x2212;0.7</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>M. pneumoniae</italic> &#xd7; HBs</bold>
</td>
<td valign="top" align="center">&#x2212;0.7</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">&#x2212;0.9</td>
<td valign="top" align="center">0.08</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>M. pneumoniae</italic> &#xd7; Bb</bold>
</td>
<td valign="top" align="center">&#x2212;0.9</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">
<bold>
<italic>M. pneumoniae</italic> &#xd7; HCV</bold>
</td>
<td valign="top" align="center">&#x2212;0.9</td>
<td valign="top" align="center">0.08</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">
<bold>Bb &#xd7; Enterovirus</bold>
</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">1</td>
<td valign="top" align="center">0.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>PMR, persistent moderate rejection; NR, no rejection; PVB19, parvovirus B19; HCV, hepatitis C virus; Bb, Borrelia burgdorferi.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_6">
<title>Transmission Electron Microscopy</title>
<p>Also, some cases in which high myocardial tissue antigenic expression of infectious agents was found by IHC were studied by electron microscopy, which revealed morphologies compatible with microorganisms in symbiosis, as demonstrated in <xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5A&#x2013;C</bold>
</xref>.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>
<bold>(A)</bold> Photomicrography of PMR case exibiting myocardial fibers (M) with severe myocytolysis (*) and mitochondria with cristolysis (green arrow), large and long borrelias at the extracelular matrix (red arrows); <bold>(B)</bold> Mild rejection case with myocardial fibers well-preserved (M), mithocondria without myocytolysis (green arrows), and mild intracellular edema; <bold>(C)</bold> NR case exibiting thinner and smaller Borrelia (red arrow) in the interstitium, Mycoplasma (M) and Enterovirus (yellow arrows).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-11-732276-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Different microbiomes may explain a chronic inflammatory state, a more pathogenic microbiome related with more inflammation, and severity of the disease (<xref ref-type="bibr" rid="B37">NIH, 2021</xref>). The loss of cardiac mass that may lead to enlargement of the ventricular chamber and the thinning of ventricular walls is highly correlated with HF and mortality (<xref ref-type="bibr" rid="B19">Harvey and Leinwand, 2011</xref>).</p>
<p>In the present study, a morphomolecular characterization and quantification of <italic>M. pneumoniae</italic>, Bb, HHV6, HBs, HBc, HCV, and PVB19 in the explanted hearts of patients with DCM detected different microbiomes. Previously, we have already detected a high incidence of Bb, HHV6, and HBc antigens in patients with DCM, suggesting a causal relationship of these microorganisms in the pathogenesis of the disease (<xref ref-type="bibr" rid="B31">Mangini et&#xa0;al., 2015</xref>). HF in Chagas disease was also associated with microorganisms in symbiosis (<xref ref-type="bibr" rid="B20">Higuchi et&#xa0;al., 2009</xref>). Other groups also described contribution of microbial communities in the pathogenicity and worse prognosis of the diseases (<xref ref-type="bibr" rid="B11">Dess&#xec; et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B17">Hansen et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B41">Schwabe and Jobin, 2013</xref>).</p>
<p>In explanted hearts of the group had an outcome of PMR, there was higher expression of <italic>M. pneumoniae</italic> antigens and macrophages, in accordance with the findings of Nakayama et&#xa0;al. that excessive immune activation in the myocardium mediated by T lymphocytes and macrophages was associated with a worse prognosis in patients with DCM (<xref ref-type="bibr" rid="B36">Nakayama et&#xa0;al., 2017</xref>). A negative correlation between the amount of <italic>M. pneumoniae</italic> with Bb, HCV, PVB19, and HBs suggest that a microbial community having larger numbers of infectious agents in symbiosis favors increased inflammation and increased capacity of these agents to remain in the patients and to develop persistent myocardial inflammation in the donor heart after CT.</p>
<p>Classically, mycoplasmas act as extracellular parasites, and the pathogenicity is dependent on the attachment sites and the onset of injury to the host cell membrane (<xref ref-type="bibr" rid="B9">Collier and Clyde, 1971</xref>). Their presence may stimulate hyperactive macrophages and activate natural killer cells, in addition to stimulating the proliferation of T and B cells and expression of class I and II molecules of the major histocompatibility complex inducing fibroblast apoptosis (<xref ref-type="bibr" rid="B39">Razin et&#xa0;al., 1998</xref>; <xref ref-type="bibr" rid="B48">Yang et&#xa0;al., 2002</xref>). Although <italic>M. pneumoniae</italic> is classically considered an extracellular pathogen, in certain circumstances such as low immune system resistance or increased pathogenicity of the infectious agents, this bacterium can live and replicate intracellularly in human cells (<xref ref-type="bibr" rid="B3">Baseman et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B49">Yavlovich et&#xa0;al., 2004</xref>). Residence in an intracellular reservoir may explain its ability to establish chronic infection, as what occurs in asthmatic patients, possibly shielded from the host&#x2019;s immune response and antibiotic action (<xref ref-type="bibr" rid="B32">Martin et&#xa0;al., 2001</xref>; <xref ref-type="bibr" rid="B18">Hardy et&#xa0;al., 2002</xref>).</p>
<p>Our correlation findings indicate an intimate relationship between <italic>M. pneumoniae</italic> and Bb in the PMR group, possibly leading to their increased virulence, represented by higher numbers of active macrophages. Mycoplasmas have the ability of stimulating macrophage proliferation (<xref ref-type="bibr" rid="B19">Harvey and Leinwand, 2011</xref>; <xref ref-type="bibr" rid="B31">Mangini et&#xa0;al., 2015</xref>). Favoring this hypothesis, the PMR group was the only group to present correlations between mycoplasma and different viruses, probably increasing the pathogenicity of this bacterium to live and replicate intracellularly in human cells (<xref ref-type="bibr" rid="B17">Hansen et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B20">Higuchi et&#xa0;al., 2009</xref>) and controlling virus proliferation, thereby explaining negative correlations. Although p-values sometimes were not statistically significant, we consider these results important for discussion.</p>
<p>Studies have shown that DCM may result from viral myocarditis due to the persistence of viruses in cardiomyocytes (<xref ref-type="bibr" rid="B29">Lotze et&#xa0;al., 2004</xref>; <xref ref-type="bibr" rid="B34">Moimas et&#xa0;al., 2012</xref>). HHV6 can infect cell types like monocytes, macrophages, fibroblasts, and endothelial cells (<xref ref-type="bibr" rid="B43">Stewart et&#xa0;al., 2011</xref>). After the primary infection, HHV6 persists in the latency state in the host, where the viral genome is harbored as circular DNA in several cells, and can be reactivated later, especially during periods of immunosuppression (<xref ref-type="bibr" rid="B43">Stewart et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B42">Seitaro, 2019</xref>). In addition to enteroviruses, PVB19 has been associated with the pathogenesis of myocarditis; however, these findings are controversial because this virus can also be found in the heart of healthy individuals (<xref ref-type="bibr" rid="B47">Verdonschot et&#xa0;al., 2016</xref>).</p>
<p>HCV development-associated cardiomyopathy can occur in susceptible patients in whom the viral and immunological mechanisms can produce myocardial and cardiovascular damage, such as plaque enlargement in the carotid arteries (<xref ref-type="bibr" rid="B14">Fukui et&#xa0;al., 2003</xref>; <xref ref-type="bibr" rid="B40">Sanchez and Bergasa, 2008</xref>). In addition, a recent study showed that HCV-positive patients had higher mortality rates for cardiovascular diseases than HCV-negative patients (<xref ref-type="bibr" rid="B6">Cacoub et&#xa0;al., 2016</xref>), evidencing the importance of this virus in heart disease. However, none of these studies considered the possibility of a microbiome containing mycoplasma and viruses.</p>
<p>The MR group did not have a correlation between microorganisms, suggesting that when there is no symbiotic coinfection, the infectious agents are more susceptible to pulse therapy.</p>
<p>Coinfection with <italic>M. pneumoniae</italic> may exacerbate Lyme disease by modulating the immune system, and this may be one of the causes of resistance to therapy by the synergistic-pathological mechanism (<xref ref-type="bibr" rid="B4">Berghoff, 2012</xref>). The prevalence of Bb in cardiac involvement has been increasingly evident, being detected in endomyocardial samples of patients with suspected inflammatory heart disease (<xref ref-type="bibr" rid="B23">Karatolios et&#xa0;al., 2015</xref>). Furthermore, similar findings have suggested that Central Europe represents an endemic area with a relatively high frequency of DCM related to Bb (<xref ref-type="bibr" rid="B26">Kub&#xe1;nek et&#xa0;al., 2012</xref>).</p>
<p>In the NR group, high numbers of HHV6 antigens and genes, high numbers of PVB19 antigens, and a low percentage of <italic>M. pneumoniae</italic> antigens associated with an increase in the mean numbers of B cells and higher HLA class II expression suggest that this group has the most effective immune system, resulting in better control of microorganisms.</p>
<p>This work shows that despite the high prevalence of HHV6 and PVB19 in the NR group, the coinfection without the participation of microorganisms such as <italic>M. pneumoniae</italic> stimulates an immune response more effectively, controlling the virus&#x2019;s infection and consequently helping to prevent the development of MR (<xref ref-type="bibr" rid="B1">Alizon and van Baalen, 2008</xref>; <xref ref-type="bibr" rid="B33">Mideo, 2009</xref>).</p>
<p>Microbiome presenting an interaction between different species of microorganisms, for example, in our present work of mycoplasma, borrelia, and viruses, leads to the development of more resistant and productive symbiotic forms, than the isolated forms as described in the literature (<xref ref-type="bibr" rid="B37">NIH, 2021</xref>). The presence of microorganisms as host symbionts is an important aim of the search for an explanation of the theory of infection; thus, it is an increasingly studied subject (<xref ref-type="bibr" rid="B22">Hussa and Goodrich-Blair, 2013</xref>). Also, we intend to continue this research in order to clarify if microbiome represented by symbiosis predominantly between bacteria <italic>M. pneumoniae</italic> and <italic>B. burgdorferi</italic> with viruses induces release of small extracellular vesicles (sEVs) associated with abnormal cellular immune response, as described in the literature (<xref ref-type="bibr" rid="B10">Christodoulides et&#xa0;al., 2018</xref>), and if these are present in the rejection episodes in morphomolecular studies of biopsies after CT (<xref ref-type="bibr" rid="B15">Govender et al, 2020</xref>). These studies may support the concept that symbiosis with viruses may provide benefit to the main symbiont by exploiting sEVs as a vehicle for intercellular communications and modifying host immune response activation.</p>
</sec>
<sec id="s5">
<title>Conclusion</title>
<p>Microbiome formed by bacteria and virus close interaction may be the causal and/or perpetuating factor of myocardial injury in patients with idiopathic DCM. Our initial findings, in a small number of cases, suggest that the morphomolecular characterization of microorganisms and inflammation in the myocardium of explanted hearts in CT patients may indicate different prognoses regarding intensities of myocardial rejection episodes. Further studies with increased number of patients and that analyze the endomyocardial biopsies in the follow-up of CT are necessary.</p>
<sec id="s5_1">
<title>Study Limitations</title>
<p>We are aware of the limitations of the study, mainly in relation to the size of the sample. However, due to the importance of the findings, and to support the idea that the presence of more virulent microbiome associated with inflammation could be influencing the pathogenesis of DCM, we intend to evaluate endomyocardial follow-up biopsy to verify the findings that infections present in the explanted hearts as we have demonstrated resurge in the donor&#x2019;s heart and are associated with episodes of rejection.</p>
</sec>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the Clinical Hospital of the Medical School of the University of S&#xe3;o Paulo Ethics Committee for Analysis of Research Projects under number 3703/11/121. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author Contributions</title>
<p>JP and MH: conceptualization. JP, RI, JK, CM, SP, SB, and AS: performance of laboratory examinations. JP, MH, JK, SP, and MR: interpretation of data. JP and MH: performance of statistical analyses. JP, MH, SG, and RI: writing and original manuscript draft preparation. JP, SM, and MH: contribution of clinical data. JP, MH, SG, and RI: manuscript review and editing. All co-authors participated in the formulation of the manuscript or critically reviewed it, contributed to its intellectual content, approved the version to be published, and agreed to be responsible for all aspects of the work, ensuring that issues related to the accuracy or integrity of any part of the work were properly investigated and resolved.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by Funda&#xe7;&#xe3;o de Amparo &#xe0; Pesquisa do Estado de S&#xe3;o Paulo (FAPESP) and Coordena&#xe7;&#xe3;o de Aperfei&#xe7;oamento de Pessoal de N&#xed;vel Superior (CAPES) numbers 2015/25786-2 and 1729745.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Samar Barros (Department of Immunology, Heart Institute of the Clinical Hospital, Medical School, University of Sao Paulo) for her support in the cloning of <italic>Borrelia</italic> gene. We also thank F&#xe9;lix Ramires, PhD, Fernanda Gallinaro Pessoa, PhD, Keila Fonseca, and Orlando Ribeiro from the Department of Cardiomyopathies (Heart Institute of the Clinical Hospital, Medical School, University of Sao Paulo) for their support in the real-time PCR. This manuscript was based on the master&#x2019;s dissertation of JP.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alizon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>van Baalen</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Multiple Infections, Immune Dynamics, and the Evolution of Virulence</article-title>. <source>Am. Nat.</source> <volume>172</volume>, <fpage>E150</fpage>&#x2013;<lpage>E168</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/590958</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bachelier</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Biehl</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Schwarz</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kindermann</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Kandolf</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Sauter</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Parvovirus B19-Induced Vascular Damage in the Heart is Associated With Elevated Circulating Endothelial Microparticles</article-title>. <source>PLoS One</source> <volume>12</volume>, <fpage>e0176311</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0176311</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baseman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Lange</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Criscimagna</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Giron</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Interplay Between Mycoplasmas and Host Target Cells</article-title>. <source>Microb. Pathog.</source> <volume>19</volume>, <fpage>105</fpage>&#x2013;<lpage>116</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/mpat.1995.0050</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berghoff</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Chronic Lyme Disease and Co-Infections: Differential Diagnosis</article-title>. <source>Open Neurol. J.</source> <volume>6</volume>, <fpage>158</fpage>&#x2013;<lpage>178</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1874205X01206010158</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bettstetter</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Garrett</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Prangishvili</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>AFV1, a Novel Virus Infecting Hyperthermophilic Archaea of the Genus Acidianus</article-title>. <source>Virology</source> <volume>315</volume>, <fpage>68</fpage>&#x2013;<lpage>79</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0042-6822(03)00481-1</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cacoub</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Comarmond</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Domont</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Savey</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Desbois</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Saadoun</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection</article-title>. <source>Ther. Adv. Infect. Dis.</source> <volume>3</volume>, <fpage>3</fpage>&#x2013;<lpage>14</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2049936115585942</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caforio</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Tona</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Bottaro</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vinci</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dequal</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Daliento</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Clinical Implications of Anti-Heart Autoantibodies in Myocarditis and Dilated Cardiomyopathy</article-title>. <source>Autoimmunity</source> <volume>41</volume>, <fpage>35</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/08916930701619235</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Blaser</surname> <given-names>M. J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The Human Microbiome: At the Interface of Health and Disease</article-title>. <source>Nat. Rev. Genet.</source> <volume>13</volume>, <fpage>260</fpage>&#x2013;<lpage>270</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrg3182</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collier</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Clyde</surname> <given-names>W. A.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>Relationships Between Mycoplasma Pneumoniae and Human Respiratory Epithelium</article-title>. <source>Infect. Immun.</source> <volume>3</volume>, <fpage>694</fpage>&#x2013;<lpage>701</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/iai.3.5.694-701.1971</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christodoulides</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Yacoubian</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Maithel</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kelesidis</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Role of Lipoproteins in Mycoplasma-Mediated Immunomodulation</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>, <elocation-id>1682</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.01682</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dess&#xec;</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Delogu</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Emonte</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Catania</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Fiori</surname> <given-names>P. L.</given-names>
</name>
<name>
<surname>Rappelli</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Long-Term Survival and Intracellular Replication of Mycoplasma Hominis in Trichomonas Vaginalis Cells: Potential Role of the Protozoon in Transmitting Bacterial Infection</article-title>. <source>Infect. Immun.</source> <volume>73</volume>, <fpage>1180</fpage>&#x2013;<lpage>1186</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.73.2.1180-1186.2005</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duarte</surname> <given-names>M. I. S.</given-names>
</name>
<name>
<surname>Mariano</surname> <given-names>O. N.</given-names>
</name>
<name>
<surname>Takakura</surname> <given-names>C. F.</given-names>
</name>
<name>
<surname>Everson</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Corbett</surname> <given-names>C. E.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>A Fast Method for Processing Biologic Material for Electron Microscopic Diagnosis in Infectious Disease</article-title>. <source>Ultrastruct. Pathol.</source> <volume>16</volume>, <fpage>475</fpage>&#x2013;<lpage>482</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/01913129209057832</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felker</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Hare</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Hruban</surname> <given-names>R. H.</given-names>
</name>
<name>
<surname>Clemetson</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Howard</surname> <given-names>D. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Underlying Causes and Long-Term Survival in Patients With Initially Unexplained Cardiomyopathy</article-title>. <source>N. Engl. J. Med.</source> <volume>342</volume>, <fpage>1077</fpage>&#x2013;<lpage>1084</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJM200004133421502</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukui</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kitagawa</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Yoshikawa</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Hepatitis C Virus and Atherosclerosis in Patients With Type 2 Diabetes</article-title>. <source>JAMA</source> <volume>289</volume>, <fpage>1245</fpage>&#x2013;<lpage>1246</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.289.10.1245-b</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Govender</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yamamoto</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Budnik</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Fichorova</surname> <given-names>R. N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Role of Small Extracellular Vesicles in Viral-Protozoan Symbiosis: Lessons From Trichomonasvirus in an Isogenic Host Parasite Model</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>:<elocation-id>591172</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.591172</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilherme</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Postol</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Barros</surname> <given-names>S. F.</given-names>
</name>
<name>
<surname>Higa</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Alencar</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lastre</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>A Vaccine Against S. Pyogenes: Design and Experimental Immune Response</article-title>. <source>Methods</source> <volume>49</volume>, <fpage>316</fpage>&#x2013;<lpage>321</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ymeth.2009.03.024</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Rainey</surname> <given-names>P. B.</given-names>
</name>
<name>
<surname>Haagensen</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Molin</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Evolution of Species Interactions in a Biofilm Community</article-title>. <source>Nature</source> <volume>445</volume>, <fpage>533</fpage>&#x2013;<lpage>536</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature05514</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hardy</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Jafri</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Olsen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hatfield</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Iglehart</surname>
</name>
<name>
<surname>Rogers</surname> <given-names>B. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2002</year>). <article-title>Mycoplasma Pneumoniae Induces Chronic Respiratory Infection, Airway Hyperreactivity, and Pulmonary Inflammation: A Murine Model of Infection-Associated Chronic Reactive Airway Disease</article-title>. <source>Infect. Immun.</source> <volume>70</volume>, <fpage>649</fpage>&#x2013;<lpage>654</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.70.2.649-654.2002</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Leinwand</surname> <given-names>L. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cellular Mechanisms of Cardiomyopathy</article-title>. <source>J. Cell Biol.</source> <volume>194</volume>, <fpage>355</fpage>&#x2013;<lpage>365</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1083/jcb.201101100</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higuchi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kawakami</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ikegami</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Clementino</surname> <given-names>M. B. M.</given-names>
</name>
<name>
<surname>Kawamoto</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Reis</surname> <given-names>M. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Do Archaea and Bacteria Co-Infection Have a Role in the Pathogenesis of Chronic Chagasic Cardiopathy</article-title>? <source>Mem. Inst. Oswaldo Cruz.</source> <volume>104</volume>, <fpage>199</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/s0074-02762009000900026</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Human Microbiome Project - Home NIH Common Fund</collab>
</person-group> (<year>2021</year>). Available at: <uri xlink:href="https://commonfund.nih.gov/hmp">https://commonfund.nih.gov/hmp</uri> (Accessed <access-date>May 29, 2021</access-date>).</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussa</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Goodrich-Blair</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>It Takes a Village: Ecological and Fitness Impacts of Multipartite Mutualism</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>67</volume>, <fpage>161</fpage>&#x2013;<lpage>178</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-micro-092412-155723</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karatolios</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Maisch</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pankuweit</surname>
</name>
</person-group> (<year>2015</year>). <article-title>Suspected Inflammatory Cardiomyopathy: Prevalence of Borrelia Burgdorferi in Endomyocardial Biopsies With Positive Serological Evidence</article-title>. <source>Herz</source> <volume>40</volume>, <fpage>91</fpage>&#x2013;<lpage>95</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00059-014-4118-x</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Matsumori</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Dilated Cardiomyopathy Update: Infectious-Immune Theory Revisited</article-title>. <source>Heart Fail Rev.</source> <volume>18</volume>, <fpage>703</fpage>&#x2013;<lpage>714</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10741-013-9401-z</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koskiniemi</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>CNS Manifestations Associated With Mycoplasma Pneumoniae Infections: Summary of Cases at the University of Helsinki and Review</article-title>. <source>Clin. Infect. Dis.</source> <volume>17</volume>, <fpage>S52</fpage>&#x2013;<lpage>S57</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/clinids/17.supplement_1.s52</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kub&#xe1;nek</surname> <given-names>M.</given-names>
</name>
<name>
<surname>&#x160;ramko</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Berenov&#xe1;</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hul&#xed;nsk&#xe1;</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hrb&#xe1;&#x10d;kov&#xe1;</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Malu&#x161;kov&#xe1;</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Detection of Borrelia Burgdorferi Sensu Lato in Endomyocardial Biopsy Specimens in Individuals With Recent-Onset Dilated Cardiomyopathy</article-title>. <source>Eur. J. Heart Fail.</source> <volume>14</volume>, <fpage>588</fpage>&#x2013;<lpage>596</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/eurjhf/hfs027</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lautenschlager</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Razonable</surname> <given-names>R. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Human Herpesvirus-6 Infections in Kidney, Liver, Lung, and Heart Transplantation: Review</article-title>. <source>Transpl. Int.</source> <volume>25</volume>, <fpage>493</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1432-2277.2012.01443.x</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ljungman</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Human Herpesvirus-6 Infection in Solid Organ and Stem Cell Transplant Recipients</article-title>. <source>J. Clin. Virol.</source> <volume>37</volume>, <fpage>S87</fpage>&#x2013;<lpage>S91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1386-6532(06)70018-X</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lotze</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Egerer</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Tresselt</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Gl&#xfc;ck</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Dannberg</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Stelzner</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2004</year>). <article-title>Frequent Detection of Parvovirus B19 Genome in the Myocardium of Adult Patients With Idiopathic Dilated Cardiomyopathy</article-title>. <source>Med. Microbiol. Immunol.</source> <volume>193</volume>, <fpage>75</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00430-003-0211-0</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luedde</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Winkler</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Heinsen</surname> <given-names>F. A.</given-names>
</name>
<name>
<surname>R&#xfc;hlemann</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Spehlmann</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Bajrovic</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>20017</year>). <article-title>Heart Failure is Associated With Depletion of Core Intestinal Microbiota</article-title>. <source>ESC Heart Fail.</source> <volume>4</volume>, <fpage>282</fpage>&#x2013;<lpage>290</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ehf2.12155</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Higuchi</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Kawakami</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Reis</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Ikegami</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Palomino</surname> <given-names>S. A. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Infectious Agents and Inflammation in Donated Hearts and Dilated Cardiomyopathies Related to Cardiovascular Diseases, Chagas&#x2019; Heart Disease, Primary and Secondary Dilated Cardiomyopathies</article-title>. <source>Int. J. Cardiol.</source> <volume>178</volume>, <fpage>55</fpage>&#x2013;<lpage>62</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijcard.2014.10.133</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Kraft</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>H. W.</given-names>
</name>
<name>
<surname>Berns</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Cassell</surname> <given-names>G. H.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>A Link Between Chronic Asthma and Chronic Infection</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>107</volume>, <fpage>595</fpage>&#x2013;<lpage>601</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1067/mai.2001.113563</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mideo</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Parasite Adaptations to Within-Host Competition</article-title>. <source>Trends Parasitol.</source> <volume>25</volume>, <fpage>261</fpage>&#x2013;<lpage>268</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pt.2009.03.001</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moimas</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zacchigna</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Merlo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Buiatti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Anzini</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Dreas</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Idiopathic Dilated Cardiomyopathy and Persistent Viral Infection: Lack of Association in a Controlled Study Using a Quantitative Assay</article-title>. <source>Heart Lung Circ.</source> <volume>21</volume>, <fpage>787</fpage>&#x2013;<lpage>793</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.hlc.2012.07.013</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagashima</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Higakib</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Satoha</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Nakanoc</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Cardiac Thrombus Associated With Mycoplasma Pneumoniae Infection</article-title>. <source>Interact. Cardiovasc. Thorac. Surg.</source> <volume>11</volume>, <fpage>849</fpage>&#x2013;<lpage>851</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1510/icvts.2010.242115</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakayama</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sugano</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yokokawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Nagai</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Matsuyama</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ohta-Ogo</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Clinical Impact of the Presence of Macrophages in Endomyocardial Biopsies of Patients With Dilated Cardiomyopathy</article-title>. <source>Eur. J. Heart Fail.</source> <volume>19</volume>, <fpage>490</fpage>&#x2013;<lpage>498</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ejhf.767</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="other">
<person-group person-group-type="author">
<collab>NIH</collab>
</person-group>. (<year>2021</year>). <article-title>Human Microbiome Project - Home NIH Common Fund</article-title>. Available online at: <uri xlink:href="https://commonfund.nih.gov/hmp/">https://commonfund.nih.gov/hmp/</uri> (accessed March 10, 2021).</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palecek</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kuchynka</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Hulinska</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Schramlova</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hrbackova</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Vitkova</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Presence of Borrelia Burgdorferi in Endomyocardial Biopsies in Patients With New-Onset Unexplained Dilated Cardiomyopathy</article-title>. <source>Med. Microbiol. Immunol.</source> <volume>199</volume>, <fpage>139</fpage>&#x2013;<lpage>143</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00430-009-0141-6</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Razin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yogev</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Naot</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Molecular Biology and Pathogenicity of Mycoplasmas</article-title>. <source>Microbiol. Mol. Biol. Rev.</source> <volume>62</volume>, <fpage>1094</fpage>&#x2013;<lpage>1156</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.62.4.1094-1156.1998</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Bergasa</surname> <given-names>N. V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Hepatitis C Associated Cardiomyopathy: Potential Pathogenic Mechanisms and Clinical Implications</article-title>. <source>Med. Sci. Monit.</source> <volume>14</volume>, <fpage>RA55</fpage>&#x2013;<lpage>RA63</lpage>.</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwabe</surname> <given-names>R. F.</given-names>
</name>
<name>
<surname>Jobin</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The Microbiome and Cancer</article-title>. <source>Nat. Rev. Cancer.</source> <volume>13</volume>, <fpage>800</fpage>&#x2013;<lpage>812</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc3610</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seitaro</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Review Genetic and non-Genetic Determinants of Clinical Phenotypes in Cardiomyopathy</article-title>. <source>J. Cardiol.</source> <volume>73</volume>, <fpage>187</fpage>&#x2013;<lpage>190</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jjcc.2018.11.001</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>Lopez-Molina</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gottumukkala</surname> <given-names>R. V.</given-names>
</name>
<name>
<surname>Rosner</surname> <given-names>G. F.</given-names>
</name>
<name>
<surname>Anello</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Hecht</surname> <given-names>J. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Myocardial Parvovirus B19 Persistence: Lack of Association With Clinicopathologic Phenotype in Adults With Heart Failure</article-title>. <source>Circ. Heart Fail.</source> <volume>4</volume>, <fpage>71</fpage>&#x2013;<lpage>78</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.110.958249</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Winters</surname> <given-names>G. L.</given-names>
</name>
<name>
<surname>Fishbein</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Tazelaar</surname> <given-names>H. D.</given-names>
</name>
<name>
<surname>Kobashigawa</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Abrams</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection</article-title>. <source>J. Heart Lung Transpl.</source> <volume>24</volume>, <fpage>1710</fpage>&#x2013;<lpage>1720</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.healun.2005.03.019</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>W. W.</given-names>
</name>
<name>
<surname>Kitai</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Hazen</surname> <given-names>S. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Gut Microbiota in Cardiovascular Health and Disease</article-title>. <source>Circ. Res.</source> <volume>120</volume>, <fpage>1183</fpage>&#x2013;<lpage>1196</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309715</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiveron</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Pomerantzeff</surname> <given-names>P. M. A.</given-names>
</name>
<name>
<surname>Higuchi</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Reis</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Kawakami</surname> <given-names>J. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Infectious Agents is a Risk Factor for Myxomatous Mitral Valve Degeneration: A Case Control Study</article-title>. <source>BMC Infect. Dis.</source> <volume>17</volume>, <fpage>297</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12879-017-2387-8</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verdonschot</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hazebroek</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Merken</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Debing</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Dennert</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Rocca</surname> <given-names>H. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Relevance of Cardiac Parvovirus B19 in Myocarditis and Dilated Cardiomyopathy: Review of the Literature</article-title>. <source>Eur. J. Heart Fail.</source> <volume>18</volume>, <fpage>1430</fpage>&#x2013;<lpage>1441</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ejhf.665</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hooper</surname> <given-names>W. C.</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Talkington</surname> <given-names>D. F.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Regulation of Proinflammatory Cytokines in Human Lung Epithelial Cells Infected With Mycoplasma Pneumoniae</article-title>. <source>Infect. Immunol.</source> <volume>70</volume>, <fpage>3649</fpage>&#x2013;<lpage>3655</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.70.7.3649-3655.2002</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yavlovich</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tarshis</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Rottem</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Internalization and Intracellular Survival of Mycoplasma Pneumoniae by non-Phagocytic Cells</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>233</volume>, <fpage>241</fpage>&#x2013;<lpage>246</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.femsle.2004.02.016</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>